
Welcome to Altitude, the bi-monthly drop from Cirrus Capital Partners. We write for founders and finance pros building at the highest level. Expect sharp insights, market movers, and operator-grade tips.
Cirrus News & Views
Welcome back to Altitude!
No major company news to report this cycle, which, honestly, might be the healthier state of affairs; it means the team's been heads down on client work rather than press releases. Rest assured, plenty of exciting updates to come!
Two events worth putting on your calendar if you’re a consumer brand founder, non-bank lender, or advisor:
We'll be at Beanstalk in New York this month, the consumer brands gathering that's become one of our favorite places to meet founders before they need us. And we're already booking meetings for the B2B Finance Expo in Las Vegas in October — if you'll be there and want to grab some time, reply to this email.
Recent Cirrus Term Sheets & Transactions
$30M bank facility ($20M revolving / $10M term). Private credit lender, used to support origination capacity as the underlying loan book scaled.
$20M senior-secured revolving-to-term facility. Auto lender structured to convert from revolver to term financing as the borrowing base matured.
$15M senior-secured credit facility. Growth-stage operating company, structure still being finalized. Up to $15M in total availability with $5M funded at close, a four-year term, cash-pay interest without PIK, and a small equity kicker.
$7.5M senior facility. Real estate lender, supporting balance-sheet growth ahead of a broader capital raise.
$3M receivables purchase facility. Media/ad-tech operating company, advised by Cirrus. Structured as a purchase of eligible receivables at up to 90% advance rate rather than a traditional loan. No financial covenants, no equity given up. This is about as clean an example of "borrow against what you've already earned" as we see.
LeBond James 📈

Gif by espn on Giphy
What LeBron James and Drake teach founders about the real cost of capital.
In 2018, while still playing for the Cavaliers, LeBron James did something almost no professional athlete had done at that scale: he turned himself into a bond.
An LLC he controls, King James Funding, sold nearly $300 million in bonds to two Midwestern life insurers, collateralized by decades of his future income — including his lifetime Nike deal. The bonds paid 4.8%, don't mature until 2049, and he came back for roughly $60 million more in 2022.
He didn't sell a piece of himself. He borrowed against a piece of himself, at a fixed cost, and kept every dollar of upside above that cost.
This past week, Drake did the opposite with a comparably durable asset. Authentic Brands Group acquired a 51% stake in the intellectual property behind OVO, Drake's lifestyle brand, with Drake retaining a 44% stake and Vince Holding Corp. taking the remaining 5%. Terms of the cash consideration weren't disclosed, but the structure is unambiguous: growth capital and operating infrastructure, paid for with permanent equity dilution below majority ownership.
Two people, sitting on two versions of the same underlying asset — predictable, contracted future income — and they made opposite decisions. That's not a celebrity curiosity. It's the exact decision every growing company faces at its own inflection point, and most get it backward.
Here's the thesis: founders reflexively raise equity when they hit a growth moment, even when they're sitting on the kind of contracted, visible revenue that would support debt instead — and the market's obsession with "raising a round" as the default growth move is optimizing for the wrong variable. Growth equity funds just pulled in a record $33.2 billion in the first half of this year, per Preqin — up 36% year-over-year. That's a lot of capital chasing the assumption that dilution is simply what growth costs. For a lot of businesses, it doesn't have to be.
If you have SaaS ARR, franchise royalties, or recurring service contracts — income that's visible, verifiable, and reasonably durable — debt against that income is frequently the more capital-efficient tool. You pay a fixed cost. You keep the upside. You don't spend six months and a chunk of your cap table convincing a VC of a story you could instead just prove with a cash-flow statement.
The strongest counterargument is real, and it's the reason equity dominates growth-stage financing to begin with: debt has fixed obligations that equity doesn't.
LeBron's income was about as close to guaranteed as future cash flow gets — a signed endorsement contract with one of the most stable brands on earth. A pre-revenue startup with lumpy, unproven cash flow has no business taking on fixed debt service; a bad quarter doesn't just hurt equity holders, it can trigger default.
Debt is a tool for certainty, not for hope.
That's exactly why it's underused by companies that actually have earned the right to use it, and overused in the popular imagination by companies that haven't.
For Founders and Operators: Before defaulting to a raise, ask honestly whether your revenue is contracted or recurring enough to be lent against. If it is, price out what a debt facility costs against what an equity round costs in permanent ownership — the math is rarely close once you run it.
For Finance Leaders: Build the reporting infrastructure (clean AR aging, revenue verification, debtor concentration data) before you need it; it's the difference between a fast non-dilutive close and a six-month equity process.
For Investors and Lenders: The businesses avoiding capital altogether right now aren't necessarily the safest ones — sometimes they're just underleveraged relative to the asset quality they're sitting on, and there's a real opportunity in helping them see it.
Drake's deal isn't a mistake — Authentic brings distribution and operating muscle a pure capital infusion couldn't. But if OVO's cash flows had been as contracted and predictable as James's endorsement income, a debt-first structure might have gotten him the same growth capital without handing over control of the majority stake.
The lesson isn't "debt good, equity bad." It's that most founders never actually run the comparison before reaching for the term sheet that dilutes them.
The most interesting thing about James's 2018 deal is that it's only surfacing now — because deals like it are private by construction.
The next time you're staring down a growth round, ask what you're not seeing in your own market: how many of your competitors already made the other choice, quietly, years ago.
What Caught Our Eye This Week
Growth Equity Funds Just Had Their Best First Half On Record
US growth equity funds raised a record $33.2 billion in H1 2026, according to Preqin data reported by the Financial Times — 36% higher than the same period last year, despite fewer managers actually coming to market.
Why It Matters: Capital is concentrating among fewer, more selective managers, and valuations have reset to levels below 2021 peaks, creating real entry-point opportunities. For founders, it means growth equity is genuinely available again — which makes the debt-versus-equity decision in this edition's lead article more relevant, not less.
Nvidia Keeps Becoming the Banker for its Own Customers
Nvidia's latest move — a $1.5 billion investment in SB Energy, the SoftBank-backed developer building an OpenAI data center campus — adds another layer to what analysts are calling "circular financing": Nvidia funds the infrastructure, the infrastructure gets leased to Nvidia's customers, who fill it with Nvidia chips purchased partly through financing Nvidia itself arranged.
Why It Matters: This is a genuinely different animal from the debt-vs-equity question facing most operating companies — it's vendor financing at a scale that concentrates risk in a handful of interlocking balance sheets worth watching as a leading indicator of AI capex sustainability, and a reminder that not all "non-dilutive capital" carries the same risk profile.
Bill Gates Says Society isn't Ready for What AI Does Next
In a nearly 6,000-word essay, Gates argued the AI transition will be "one of the most turbulent times in human history," with particular concern for lower-wage workers displaced faster than institutions can respond, and floated the idea of a robot tax.
Why It Matters: Whatever you think of the specific policy proposals, the labor disruption question is directly relevant to lower-middle-market operators — many of whom are already automating roles faster than they're backfilling them, with real implications for workforce planning and margin structure over the next 24 months.
Markets & Assets At-A-Glance
TL;DR
Rates moved up hard this week — the 10-year touched its highest level since late 2023 on renewed deficit and inflation worries — while equities shrugged it off and posted modest gains after a rocky start to September.
The Fed holds its next meeting September 15–16, and three regional presidents are already on record favoring a hike.
Asset / Market | Value | Altitude Take |
|---|---|---|
SOFR Rate | 3.66% | 🟡 Overnight funding costs haven't moved; the real story is happening further out the curve. |
Fed Funds Target Range | 3.50%–3.75% | 🟡 Held for a fifth straight meeting, but three regional Fed presidents dissented in favor of a hike in July — watch September 16 closely. |
2-Year Treasury | 4.38% | 🟡 Pricing in real hike risk, not just deficit noise. |
10-Year Treasury | 4.79% | 🟡 This is the number that actually drives your borrowing costs — and it's moving in the wrong direction for anyone financing growth with debt right now. |
S&P 500 | 7,600.60 | 🟡 Near-record territory despite the rate backdrop — equity markets aren't yet pricing in real credit stress. |
Nasdaq Composite | 26,217.83 | 🟡 Tech holding up better than rate-sensitive sectors. |
Russell 2000 | 2,953.17 | 🟡 Small caps remain the most rate-sensitive barometer in the market — worth watching if the 10-year keeps climbing. |
U.USnemployment Rate | 4.1% | 🟡 July payrolls unexpectedly fell by 23,000; August's report lands Friday, September 4. |
What It Means: The 10-year at a two-year high is the number that matters most for anyone in this audience raising or refinancing debt right now — spreads on top of that benchmark just got more expensive, even with SOFR and Fed Funds unchanged.
If you're structuring a facility this quarter, lock terms sooner rather than later; the direction of travel on long rates has been consistently up since Bessent's buyback intervention lost steam in late August.
Market Movers
Venture Capital & Growth Equity Raises
Blank Street — $105M Growth Equity Round
Brooklyn-born coffee and matcha chain Blank Street closed roughly $105 million in new funding — $75 million primary, $30 million secondary — led by General Atlantic, with existing backers General Catalyst, Left Lane Capital, and Tiger Global participating.
The deal values the company at approximately $650 million, up from roughly $500 million a year ago, and funds a push into the West Coast market.
It's genuinely uncommon for a bricks-and-mortar consumer brand to pull this kind of capital from investors better known for backing software; General Catalyst's portfolio includes Airbnb and Stripe.
Blank Street's pitch has been per-unit profitability within a month of opening, which is the kind of discipline that makes a growth round look more like the LeBron model than the Drake one — capital raised from a position of proven, repeatable cash generation rather than pure growth-story potential.
Vals AI. $40M Series A led by a16z at a $400M valuation. The AI evaluation startup, which builds independent benchmarks of how frontier models perform on real-world professional tasks, says revenue has risen eightfold since 2025.
Metriport. $26M raised from Matrix. The company builds API infrastructure to access and manage healthcare data, as well as for EHR integration.
Alloy Robotics. $11.5M seed from Square Peg.
Henry. $16.5M Series A led by FirstMark.
M&A (Big Buys / Strategic Deals)

Gif by abcnetwork on Giphy
McKesson acquires Precision Medicine Group for $2.25B
Healthcare giant McKesson signed a definitive agreement to acquire Precision Medicine Group, a global provider of clinical research and biopharma commercialization services, for approximately $2.25 billion.
The deal falls under McKesson's Oncology & Multispecialty segment and is part of a broader strategy to shed non-core assets in favor of faster-growing specialty care.
Middle market ($50M–$1B): We came up short on a credible, adequately-sourced deal in this range within the coverage window — rather than force a fit, we're flagging the gap. If you've seen something in this range worth including next time, send it our way.
Smaller / Undisclosed:
Authentic Brands Group acquires 51% of OVO. Drake's lifestyle brand, with Drake retaining 44% and Vince Holding Corp. taking 5%. Terms not disclosed.
Constellation Wealth Capital acquires minority stake in Confluence Financial Partners. $7.6B AUM RIA. Terms not disclosed.
Credit & Debt Financing
$100M+: Lifetime Brands — $200M ABL facility (amended and extended) + $60M second-lien term loan
Lifetime Brands completed a refinancing of its credit facilities: a new $60 million second-lien term loan from Pathlight Capital replacing its existing Term Loan B, alongside an amendment and extension of its existing $200 million asset-based revolving facility, agented by JPMorgan. Both mature in August 2031.
Altitude Take: A clean example of a consumer products company extending its maturity runway ahead of a tighter rate environment rather than waiting for a refinancing wall.
$10M–$100M:
Cirrus-advised — $15M senior-secured facility. See Recent Transactions above.
Eclipse Business Capital — $55M ABL facility. For a regional building materials supplier, refinancing existing bank debt and adding working capital flexibility.
Below $10M:
Cirrus-advised — $3M receivables purchase facility. See Recent Transactions above.
Alpine Ridge Funding — $2M working capital facility. A fire protection equipment and industrial flow-control manufacturer, replacing an existing bank facility.
Share the love!
LeBron didn't sell a piece of himself. He borrowed against a piece of himself — and kept every dollar above the cost. Most founders never run that comparison before reaching for the term sheet that dilutes them.
— @RyanRidg
Altitude is the #1 newsletter for founders, operators, dealmakers, and capital allocators aiming to reach their highest potential. 🏔️
To your growth,

Ryan Ridgway
Co-Founder & Managing Partner
Cirrus Capital Partners

Jacob Gonzalez
Co-Founder
Cirrus Capital Partners
Enjoying Altitude?
Thanks for reading! If this one landed, forward it to a founder who's about to raise a round without checking whether they could borrow instead.
